Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT2031210414Completed
Open-label, single-arm trial of azilsartan in hypertension (HTN), sponsored by Takeda. Started Dec 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT2031210414.